Brief: Redhill Biopharma Further Expands Opaganib Manufacturing Capacity For Covid-19 With Cosmo Pharmaceuticals
Jan 28 (Reuters) - Redhill Biopharma Ltd REDIF.PK :
* REDHILL BIOPHARMA FURTHER EXPANDS OPAGANIB MANUFACTURING
CAPACITY FOR COVID-19 WITH COSMO PHARMACEUTICALS
* REDHILL BIOPHARMA LTD - MANUFACTURING AGREEMENT WITH
COSMO
PHARMACEUTICALS NV TO FURTHER EXPAND MANUFACTURING CAPACITY FOR
OPAGANIB
Source text for Eikon: ID:nPn5TcTjta
Further company coverage: REDIF.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter